C07D 235/10
Radicals substituted by halogen atoms or nitro radicals
C07D235/10 (Radicals substituted by halogen atoms or nitro radicals) appears on 178 US grants and 149 published applications in this corpus.
Search patents in C07D- Granted patents
- 178
- Published applications
- 149
- Assignees
- 123
- Inventors
- 654
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 0 |
| 2002 | 4 | 5 |
| 2003 | 1 | 2 |
| 2004 | 2 | 8 |
| 2005 | 2 | 7 |
| 2006 | 1 | 7 |
| 2007 | 4 | 5 |
| 2008 | 3 | 3 |
| 2009 | 5 | 11 |
| 2010 | 6 | 11 |
| 2011 | 6 | 5 |
| 2012 | 5 | 2 |
| 2013 | 7 | 5 |
| 2014 | 5 | 9 |
| 2015 | 7 | 9 |
| 2016 | 6 | 7 |
| 2017 | 6 | 5 |
| 2018 | 4 | 8 |
| 2019 | 6 | 2 |
| 2020 | 5 | 10 |
| 2021 | 5 | 7 |
| 2022 | 3 | 2 |
| 2023 | 4 | 8 |
| 2024 | 6 | 7 |
| 2025 | 5 | 1 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of coupling a carbon containing moiety to an amine containing moiety6 Oct 2026US 12,753,155 B2Purdue Research Foundation
- Materials for reducing acids from liquid phases2 Jun 2026US 12,643,971 B2The Board of Trustees of The University of Alabama
- Substituted benzimidazole derivative and use thereof13 Jan 2026US 12,522,569 B2Chengdu FANXI Biopharma Co., Ltd.
- GLP-1 receptor agonist23 Sep 2025US 12,421,205 B2Hyundai Pharm Co., Ltd.
- Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof9 Sep 2025US 12,410,142 B2Xiamen Vivohealths Technology Co., Ltd.
- Fluorinated mu-opioid receptor agonists10 Sep 2026US 2026/0265205 A1The United State of America, as represented by the Secretary, Department of Health and Human
- Materials for reducing acids from liquid phases10 Sep 2026US 2026/0265434 A1The Board of Trustees of The University of Alabama
- Compounds that inhibit pkmyt123 Jul 2026US 2026/0207565 A1Exelixis, Inc.
- Bicyclic fused ring derivative or salt thereof and pharmaceutical composition comprising same27 Feb 2025US 2025/0066308 A1Yuhan Corporation
- Novel transglutaminase 2 inhibitor and use thereof12 Sep 2024US 2024/0300902 A1Md Biolab Co., Ltd.
Most cited
By later US patents
- Benzimidazole derivatives62US 5,314,880 ABritish Bio-Technology Limited · 1994
- Method of inhibiting neoplastic cells with benzimidazole derivatives60US 6,348,032 B1Cell Pathways, Inc. · 2002
- Bicyclic heterocyclic compounds42US 5,811,429 ABayer Aktiengesellschaft · 1998
- Compounds for inflammation and immune-related uses32US 7,709,518 B2Synta Pharmaceuticals Corp. · 2010
- Benzamide derivatives having a vasopressin antagonistic activity29US 6,207,693 B1Fujisawa Pharmaceutical Co., Ltd. · 2001